Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach.


Journal

The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665

Informations de publication

Date de publication:
05 2021
Historique:
received: 17 06 2020
revised: 12 01 2021
accepted: 13 01 2021
pubmed: 14 3 2021
medline: 29 6 2021
entrez: 13 3 2021
Statut: ppublish

Résumé

Antimicrobial misuse is common in low-income and middle-income countries (LMICs), and this practice is a driver of antibiotic resistance. We compared community-based antibiotic access and use practices across communities in LMICs to identify contextually specific targets for interventions to improve antibiotic use practices. We did quantitative and qualitative assessments of antibiotic access and use in six LMICs across Africa (Mozambique, Ghana, and South Africa) and Asia (Bangladesh, Vietnam, and Thailand) over a 2·5-year study period (July 1, 2016-Dec 31, 2018). We did quantitative assessments of community antibiotic access and use through supplier mapping, customer exit interviews, and household surveys. These quantitative assessments were triangulated with qualitative drug supplier and consumer interviews and discussions. Vietnam and Bangladesh had the largest proportions of non-licensed antibiotic dispensing points. For mild illness, drug stores were the most common point of contact when seeking antibiotics in most countries, except South Africa and Mozambique, where public facilities were most common. Self-medication with antibiotics was found to be widespread in Vietnam (55·2% of antibiotics dispensed without prescription), Bangladesh (45·7%), and Ghana (36·1%), but less so in Mozambique (8·0%), South Africa (1·2%), and Thailand (3·9%). Self-medication was considered to be less time consuming, cheaper, and overall, more convenient than accessing them through health-care facilities. Factors determining where treatment was sought often involved relevant policies, trust in the supplier and the drug, disease severity, and whether the antibiotic was intended for a child. Confusion regarding how to identify oral antibiotics was revealed in both Africa and Asia. Contextual complexities and differences between countries with different incomes, policy frameworks, and cultural norms were revealed. These contextual differences render a single strategy inadequate and instead necessitate context-tailored, integrated intervention packages to improve antibiotic use in LMICs as part of global efforts to combat antibiotic resistance. Wellcome Trust and Volkswagen Foundation.

Sections du résumé

BACKGROUND
Antimicrobial misuse is common in low-income and middle-income countries (LMICs), and this practice is a driver of antibiotic resistance. We compared community-based antibiotic access and use practices across communities in LMICs to identify contextually specific targets for interventions to improve antibiotic use practices.
METHODS
We did quantitative and qualitative assessments of antibiotic access and use in six LMICs across Africa (Mozambique, Ghana, and South Africa) and Asia (Bangladesh, Vietnam, and Thailand) over a 2·5-year study period (July 1, 2016-Dec 31, 2018). We did quantitative assessments of community antibiotic access and use through supplier mapping, customer exit interviews, and household surveys. These quantitative assessments were triangulated with qualitative drug supplier and consumer interviews and discussions.
FINDINGS
Vietnam and Bangladesh had the largest proportions of non-licensed antibiotic dispensing points. For mild illness, drug stores were the most common point of contact when seeking antibiotics in most countries, except South Africa and Mozambique, where public facilities were most common. Self-medication with antibiotics was found to be widespread in Vietnam (55·2% of antibiotics dispensed without prescription), Bangladesh (45·7%), and Ghana (36·1%), but less so in Mozambique (8·0%), South Africa (1·2%), and Thailand (3·9%). Self-medication was considered to be less time consuming, cheaper, and overall, more convenient than accessing them through health-care facilities. Factors determining where treatment was sought often involved relevant policies, trust in the supplier and the drug, disease severity, and whether the antibiotic was intended for a child. Confusion regarding how to identify oral antibiotics was revealed in both Africa and Asia.
INTERPRETATION
Contextual complexities and differences between countries with different incomes, policy frameworks, and cultural norms were revealed. These contextual differences render a single strategy inadequate and instead necessitate context-tailored, integrated intervention packages to improve antibiotic use in LMICs as part of global efforts to combat antibiotic resistance.
FUNDING
Wellcome Trust and Volkswagen Foundation.

Identifiants

pubmed: 33713630
pii: S2214-109X(21)00024-3
doi: 10.1016/S2214-109X(21)00024-3
pmc: PMC8050200
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e610-e619

Subventions

Organisme : Wellcome Trust
ID : 109595/Z/15/Z
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Références

BMC Public Health. 2020 Jul 29;20(1):1183
pubmed: 32727445
Lancet Infect Dis. 2013 Dec;13(12):1057-98
pubmed: 24252483
Lancet Infect Dis. 2011 Sep;11(9):692-701
pubmed: 21659004
Am J Epidemiol. 2013 Feb 15;177(4):361-70
pubmed: 23364878
Am J Trop Med Hyg. 2019 Jun;100(6):1378-1390
pubmed: 30994091
Lancet. 2016 Jan 9;387(10014):188-98
pubmed: 26603919
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Trop Med Int Health. 2012 Feb;17(2):211-22
pubmed: 21999394
J Pharm Policy Pract. 2018 Dec 14;11:30
pubmed: 30564369
Lancet Planet Health. 2018 Sep;2(9):e398-e405
pubmed: 30177008
Wellcome Open Res. 2017 Jul 28;2:58
pubmed: 29707652
Lancet Infect Dis. 2014 Aug;14(8):742-750
pubmed: 25022435
Lancet Glob Health. 2016 Sep;4(9):e633-41
pubmed: 27495137
J Clin Pharm Ther. 2018 Apr;43(2):302-307
pubmed: 29205419
BMC Public Health. 2019 Nov 26;19(1):1560
pubmed: 31771536
Antibiotics (Basel). 2020 Nov 07;9(11):
pubmed: 33171743
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
BMC Public Health. 2020 Jul 14;20(1):1103
pubmed: 32664902
BMJ. 2016 Feb 29;352:i1202
pubmed: 26926703
Lancet Glob Health. 2019 Jan;7(1):e119-e131
pubmed: 30554748
BMC Public Health. 2019 Jul 22;19(1):971
pubmed: 31331304
J Antimicrob Chemother. 2019 Sep 1;74(9):2788-2796
pubmed: 31257435
Isr Med Assoc J. 2007 Jan;9(1):16-20
pubmed: 17274349
Lancet Infect Dis. 2020 Feb;20(2):179-187
pubmed: 31843383
Ann Fam Med. 2009 Nov-Dec;7(6):520-6
pubmed: 19901311
Res Social Adm Pharm. 2019 Jun;15(6):627-631
pubmed: 30279131
BMC Public Health. 2015 Aug 01;15:742
pubmed: 26231758
Int J Epidemiol. 2013 Oct;42(5):1309-18
pubmed: 24159076
Public Health. 2019 Mar;168:92-101
pubmed: 30716570
Front Public Health. 2020 Mar 24;8:90
pubmed: 32266200

Auteurs

Nga T T Do (NTT)

Oxford University Clinical Research Unit, Hanoi, Vietnam.

Huong T L Vu (HTL)

Oxford University Clinical Research Unit, Hanoi, Vietnam.

Chuc T K Nguyen (CTK)

Department of Family Medicine, Hanoi Medical University, Hanoi, Vietnam.

Sureeporn Punpuing (S)

Institute for Population and Social Research, Mahidol University, Nakhonpathom, Thailand.

Wasif Ali Khan (WA)

International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.

Margaret Gyapong (M)

Institute of Health Research, University of Health and Allied Sciences, Ho, Ghana.

Kwaku Poku Asante (KP)

Kintampo Health Research Centre, Kintampo, Ghana.

Khatia Munguambe (K)

Manhiça Health Research Centre, Manhiça, Mozambique; Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.

F Xavier Gómez-Olivé (FX)

MRC-Wits Rural Public Health and Health Transitions Research Unit (Agincourt), University of the Witwatersrand, Johannesburg, South Africa.

Johannes John-Langba (J)

School of Applied Human Sciences, University of Kwazulu-Natal, Durban, South Africa.

Toan K Tran (TK)

Department of Family Medicine, Hanoi Medical University, Hanoi, Vietnam.

Malee Sunpuwan (M)

Institute for Population and Social Research, Mahidol University, Nakhonpathom, Thailand.

Esperanca Sevene (E)

Manhiça Health Research Centre, Manhiça, Mozambique; Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.

Hanh H Nguyen (HH)

Department of Family Medicine, Hanoi Medical University, Hanoi, Vietnam.

Phuc D Ho (PD)

Institute of Mathematics, Vietnam Academy of Science and Technology, Hanoi, Vietnam.

Mohammad Abdul Matin (MA)

International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.

Sabeena Ahmed (S)

International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.

Mohammad Mahbubul Karim (MM)

International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.

Olga Cambaco (O)

Manhiça Health Research Centre, Manhiça, Mozambique.

Samuel Afari-Asiedu (S)

Kintampo Health Research Centre, Kintampo, Ghana.

Ellen Boamah-Kaali (E)

Kintampo Health Research Centre, Kintampo, Ghana.

Martha Ali Abdulai (MA)

Kintampo Health Research Centre, Kintampo, Ghana.

John Williams (J)

Dodowa Health Research Centre, Dodowa, Ghana.

Sabina Asiamah (S)

Dodowa Health Research Centre, Dodowa, Ghana.

Georgina Amankwah (G)

Dodowa Health Research Centre, Dodowa, Ghana.

Mary Pomaa Agyekum (MP)

Dodowa Health Research Centre, Dodowa, Ghana.

Fezile Wagner (F)

MRC-Wits Rural Public Health and Health Transitions Research Unit (Agincourt), University of the Witwatersrand, Johannesburg, South Africa.

Proochista Ariana (P)

Nuffied Department of Clinical Medicine, University of Oxford, Oxford, UK.

Betuel Sigauque (B)

Manhiça Health Research Centre, Manhiça, Mozambique.

Stephen Tollman (S)

MRC-Wits Rural Public Health and Health Transitions Research Unit (Agincourt), University of the Witwatersrand, Johannesburg, South Africa.

H Rogier van Doorn (HR)

Oxford University Clinical Research Unit, Hanoi, Vietnam; Nuffied Department of Clinical Medicine, University of Oxford, Oxford, UK.

Osman Sankoh (O)

School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; Statistics Sierra Leone, Freetown, Sierra Leone; University Secretariat, Njala University, Njala, Sierra Leone; Heidelberg Institute for Global Health, University of Heidelberg Medical School, Heidelberg, Germany.

John Kinsman (J)

Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden.

Heiman F L Wertheim (HFL)

Oxford University Clinical Research Unit, Hanoi, Vietnam; Department of Medical Microbiology and Radboudumc Center for Infectious Diseases, Radboudumc, Nijmegen, The Netherlands. Electronic address: heiman.wertheim@radboudumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH